Pub. Date : 2012 Oct
PMID : 22561792
4 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Lithocholic acid (LCA) (10 muM), chenodeoxycholic acid (CDCA) (10 muM), or GW4064 (0.1 muM) treatment increased reporter activity in a construct including the three motifs under FXR-expressing conditions whereas LCA and not CDCA or GW4064 treatment increased the reporter activity under pregnane X receptor (PXR)-expressing conditions. | Lithocholic Acid | nuclear receptor subfamily 1 group I member 2 | Homo sapiens |
2 | Lithocholic acid (LCA) (10 muM), chenodeoxycholic acid (CDCA) (10 muM), or GW4064 (0.1 muM) treatment increased reporter activity in a construct including the three motifs under FXR-expressing conditions whereas LCA and not CDCA or GW4064 treatment increased the reporter activity under pregnane X receptor (PXR)-expressing conditions. | Lithocholic Acid | nuclear receptor subfamily 1 group I member 2 | Homo sapiens |
3 | Lithocholic acid (LCA) (10 muM), chenodeoxycholic acid (CDCA) (10 muM), or GW4064 (0.1 muM) treatment increased reporter activity in a construct including the three motifs under FXR-expressing conditions whereas LCA and not CDCA or GW4064 treatment increased the reporter activity under pregnane X receptor (PXR)-expressing conditions. | Lithocholic Acid | nuclear receptor subfamily 1 group I member 2 | Homo sapiens |
4 | Lithocholic acid (LCA) (10 muM), chenodeoxycholic acid (CDCA) (10 muM), or GW4064 (0.1 muM) treatment increased reporter activity in a construct including the three motifs under FXR-expressing conditions whereas LCA and not CDCA or GW4064 treatment increased the reporter activity under pregnane X receptor (PXR)-expressing conditions. | Lithocholic Acid | nuclear receptor subfamily 1 group I member 2 | Homo sapiens |